New evidence of durable immune response to 3 experimental Ebola vaccines helps drive new wave of vaccine development targeting a number of diseases with epidemic potential

(American Society of Tropical Medicine and Hygiene) In the midst of an increasingly volatile Ebola outbreak in the Democratic Republic of Congo, a new study presented today finds that the immune response generated by three experimental Ebola vaccines -- including one already deployed in the DRC -- persists for at least two and a half years. The study, presented at the Annual Meeting of the American Society of Tropical Medicine and Hygiene, could have implications far beyond the Ebola fight.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news